Table 5.
Proportions of latent subgroups by diagnosis
| Class Name, N (%) | AN-R‡ N (%) | AN-BP N (%) | BN N (%) | ARFID N (%) | BED N (%) | OSFED N (%) |
|---|---|---|---|---|---|---|
| “Low ACEs” † 503 (47%) | 145† (52%) | 147† (49%) | 62† (46%) | 68† (46%) | 29† (37%) | 52† (41%) |
| “Household ACEs” 347 (33%) | 81‡ (29%) | 99 (33%) | 47 (35%) | 48 (33%) | 24 (31%) | 48 (38%) |
| “Abuse ACEs” 99 (9%) | 25‡ (9%) | 20 (7%) | 10 (7%) | 17 (12%) | 14 (18%) | 13 (10%) |
| “All ACEs” 112 (10%) | 27‡ (10%) | 32 (11%) | 15 (11%) | 13 (9%) | 11 (14%) | 14 (11%) |
†Reference group of “Low ACEs” latent subgroup in categorical outcome of the multinomial logistic regression. ‡Reference group of patients with AN-R in the categorical predictor of the multinomial logistic regression. Bolded numbers represent a significant increase in the risk ratio of being in the identified latent subgroup row (vs. the “Low ACEs” subgroup) for patients with the identified diagnosis column (vs. patients with AN-R)—a comparison across four total prevalence rates. No inferential comparisons have been made between any two prevalence rates. Latent subgroup row percentages add up to 100% down each diagnosis column. Analysis was multinomial logistic regression